Silva Pharmaceuticals Limited (DSE: SILVAPHL)
Bangladesh
· Delayed Price · Currency is BDT 10.40
-0.10 (-0.95%)
At close: Dec 19, 2024
Silva Pharmaceuticals Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2016 |
| Net Income | -89.76 | -64.48 | 33.08 | 102.26 | 119.85 | 118.94 | Upgrade
|
| Depreciation & Amortization | 60.29 | 60.45 | 65.93 | 68.12 | 70.73 | 73.23 | Upgrade
|
| Other Amortization | 0.13 | 0.14 | 0.15 | 0.17 | 0.16 | 0.07 | Upgrade
|
| Other Operating Activities | 11.94 | 7.06 | -1.86 | -11.12 | 3.29 | 13.01 | Upgrade
|
| Change in Accounts Receivable | 5.31 | 3.19 | -1.71 | 14.6 | -8.79 | -4.17 | Upgrade
|
| Change in Inventory | 22.91 | 0.52 | -11.43 | -18.11 | -19.8 | -46.92 | Upgrade
|
| Change in Accounts Payable | 3.42 | 0.17 | 0.09 | 0.64 | -0.29 | 3.48 | Upgrade
|
| Change in Other Net Operating Assets | -12.87 | -3.63 | -14.15 | 4.3 | -5.76 | -7.02 | Upgrade
|
| Operating Cash Flow | 1.37 | 3.42 | 70.1 | 160.85 | 159.4 | 150.62 | Upgrade
|
| Operating Cash Flow Growth | -96.86% | -95.12% | -56.42% | 0.91% | 5.83% | -20.72% | Upgrade
|
| Capital Expenditures | -33.83 | -32.99 | -86.81 | -177.64 | -77.18 | -171.76 | Upgrade
|
| Investment in Securities | 5.2 | 63.92 | 72.32 | -13.38 | -8.63 | 48.76 | Upgrade
|
| Investing Cash Flow | -28.63 | 30.93 | -14.49 | -191.02 | -85.82 | -122.99 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 61.87 | 2.46 | 26.68 | Upgrade
|
| Total Debt Issued | 1.23 | - | - | 61.87 | 2.46 | 26.68 | Upgrade
|
| Short-Term Debt Repaid | - | -8.13 | -35.17 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -2.24 | -3.2 | -6.18 | -6.49 | -5.59 | Upgrade
|
| Total Debt Repaid | -3.95 | -10.37 | -38.37 | -6.18 | -6.49 | -5.59 | Upgrade
|
| Net Debt Issued (Repaid) | -2.72 | -10.37 | -38.37 | 55.69 | -4.04 | 21.09 | Upgrade
|
| Common Dividends Paid | -13.8 | -13.93 | -25.03 | -47.75 | -47.3 | -52.95 | Upgrade
|
| Other Financing Activities | - | - | - | - | - | -0.42 | Upgrade
|
| Financing Cash Flow | -16.52 | -24.3 | -63.4 | 7.94 | -51.34 | -32.28 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -1.33 | Upgrade
|
| Net Cash Flow | -43.78 | 10.05 | -7.78 | -22.24 | 22.25 | -5.98 | Upgrade
|
| Free Cash Flow | -32.46 | -29.57 | -16.7 | -16.8 | 82.22 | -21.14 | Upgrade
|
| Free Cash Flow Margin | -5.93% | -4.93% | -2.33% | -2.16% | 10.29% | -2.77% | Upgrade
|
| Free Cash Flow Per Share | -0.24 | -0.22 | -0.12 | -0.12 | 0.60 | -0.15 | Upgrade
|
| Cash Interest Paid | 4.04 | 3.63 | 2.73 | 4.06 | 1.74 | 0.42 | Upgrade
|
| Cash Income Tax Paid | 6.86 | 11.76 | 20.28 | 26.23 | 29.26 | 28.6 | Upgrade
|
| Levered Free Cash Flow | 4.92 | -1.27 | -28.2 | -48.45 | 53.24 | -58.5 | Upgrade
|
| Unlevered Free Cash Flow | 7.95 | 1.47 | -25.94 | -45.5 | 54.98 | -57.59 | Upgrade
|
| Change in Net Working Capital | -26.88 | -3.38 | 33.2 | 5.99 | 27.54 | 46.83 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.